$VNDA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Vanda Pharmaceuticals Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Vanda Pharmaceuticals Inc.. Get notifications about new insider transactions in Vanda Pharmaceuticals Inc. for free.

Page:   < prev 1 2 3 4 5 6 ... 8 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,50000
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM5.76250,0001,440,0000
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS15.3021,535329,3991,183,8381.2 M to 1.2 M (-1.79 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0018,75001,205,3731.2 M to 1.2 M (+1.58 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,50001,149,1231.1 M to 1.1 M (+1.10 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,50001,124,1231.1 M to 1.1 M (+1.12 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS15.30170,2252,603,7281,111,6231.3 M to 1.1 M (-13.28 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM5.76250,0001,440,0001,281,8481 M to 1.3 M (+24.23 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOGiftG0.0010,00001,031,8481 M to 1 M (-0.96 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseM0.007,500015,000
Jan 04 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseM0.0012,500025,000
Jan 04 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...SellS15.2010,367157,56588,73399.1 K to 88.7 K (-10.46 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...BuyM0.007,500099,10091.6 K to 99.1 K (+8.19 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...BuyM0.0012,500076,60064.1 K to 76.6 K (+19.50 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS15.268,568130,777118,366126.9 K to 118.4 K (-6.75 %)
Jun 19 2017VNDAVanda Pharmaceutic ...BATE KENNETHDirectorOption ExerciseA13.7510,000137,50010,000
Jun 19 2017VNDAVanda Pharmaceutic ...BATE KENNETHDirectorGrantA0.005,00005,0000 to 5 K
Jun 19 2017VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseA13.7510,000137,50010,000
Jun 19 2017VNDAVanda Pharmaceutic ...Watkins ThomasDirectorGrantA0.005,00005,0000 to 5 K
Jun 19 2017VNDAVanda Pharmaceutic ...MILANO VINCENTDirectorOption ExerciseA13.7510,000137,50010,000
Jun 19 2017VNDAVanda Pharmaceutic ...MILANO VINCENTDirectorGrantA0.005,00005,0000 to 5 K
Jun 19 2017VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseA13.7510,000137,50010,000
Jun 19 2017VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorGrantA0.005,000010,7705.8 K to 10.8 K (+86.66 %)
Jun 19 2017VNDAVanda Pharmaceutic ...COLA MICHAEL FDirectorOption ExerciseA13.7510,000137,50010,000
Jun 19 2017VNDAVanda Pharmaceutic ...COLA MICHAEL FDirectorGrantA0.005,00005,0000 to 5 K
Mar 03 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseA14.5070,0001,015,00070,000
Mar 03 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...GrantA0.0030,000050,00020 K to 50 K (+150.00 %)
Mar 03 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseA14.50275,0003,987,500275,000
Mar 03 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOGrantA0.00200,00001,041,848841.8 K to 1 M (+23.76 %)
Mar 03 2017VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...Option ExerciseA14.5070,0001,015,00070,000
Mar 03 2017VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...GrantA0.0070,0000139,72169.7 K to 139.7 K (+100.40 %)
Mar 03 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseA14.5070,0001,015,00070,000
Mar 03 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...GrantA0.0030,000039,1009.1 K to 39.1 K (+329.67 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.005,000010,000
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.005,00005,000
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...Option ExerciseM0.002,34400
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...SellS15.5110,895169,01369,72180.6 K to 69.7 K (-13.51 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.007,500080,61673.1 K to 80.6 K (+10.26 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.005,000073,11668.1 K to 73.1 K (+7.34 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.005,000068,11663.1 K to 68.1 K (+7.92 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO & Treasure ...BuyM0.002,344063,11660.8 K to 63.1 K (+3.86 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0018,750056,250
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,500025,000
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,500012,500
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.006,25000
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS15.4823,330361,242850,848874.2 K to 850.8 K (-2.67 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0018,7500874,178855.4 K to 874.2 K (+2.19 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,5000855,428842.9 K to 855.4 K (+1.48 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,5000842,928830.4 K to 842.9 K (+1.51 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.006,2500830,428824.2 K to 830.4 K (+0.76 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.005,000010,000
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.005,00005,000
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.0012,50000
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyS15.5116,300252,77654,36538.1 K to 54.4 K (+42.82 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.007,500070,66563.2 K to 70.7 K (+11.87 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.005,000063,16558.2 K to 63.2 K (+8.60 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.005,000058,16553.2 K to 58.2 K (+9.40 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.0012,500053,16540.7 K to 53.2 K (+30.74 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseM0.0012,500037,500
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...SellS15.5110,900169,0909,10020 K to 9.1 K (-54.50 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...BuyM0.007,500020,00012.5 K to 20 K (+60.00 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...BuyM0.0012,500012,5000 to 12.5 K
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseM0.007,500022,500
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseM0.0012,500037,500
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...BuyM0.007,500020,00012.5 K to 20 K (+60.00 %)
Jan 05 2017VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...BuyM0.0012,500012,5000 to 12.5 K
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.71157,6072,633,140693,171850.8 K to 693.2 K (-18.53 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.71348,2585,818,3462,035,6972.4 M to 2 M (-14.61 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.71273,6324,571,5701,599,4761.9 M to 1.6 M (-14.61 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.2468,9401,119,517850,778919.7 K to 850.8 K (-7.50 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.24152,3342,473,7522,383,9552.5 M to 2.4 M (-6.01 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.24119,6901,943,6461,873,1082 M to 1.9 M (-6.01 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.5837,044577,146919,718956.8 K to 919.7 K (-3.87 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.534,91076,2422,536,2892.5 M to 2.5 M (-0.19 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.533,85759,8911,992,7982 M to 2 M (-0.19 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.6287,8581,372,254956,7621 M to 956.8 K (-8.41 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.62119,0081,858,7862,541,1992.7 M to 2.5 M (-4.47 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.6293,5061,460,4701,996,6552.1 M to 2 M (-4.47 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.7658,997929,4981,044,6201.1 M to 1 M (-5.35 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.7679,9151,259,0612,660,2072.7 M to 2.7 M (-2.92 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.7662,791989,2722,090,1612.2 M to 2.1 M (-2.92 %)
Feb 17 2016VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP, Acting CCO & G ...Option ExerciseA0.0030,000030,000
Feb 17 2016VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP, Acting CCO & G ...Option ExerciseA7.9470,000555,80070,000
Feb 17 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseA0.0075,000075,000
Feb 17 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseA7.94175,0001,389,500175,000
Feb 17 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...Option ExerciseA0.0030,000030,000
Feb 17 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...Option ExerciseA7.9470,000555,80070,000
Feb 17 2016VNDAVanda Pharmaceutic ...Gulino Richard L.SVP & General Couns ...Option ExerciseA0.0030,000030,000
Feb 17 2016VNDAVanda Pharmaceutic ...Gulino Richard L.SVP & General Couns ...Option ExerciseA7.9470,000555,80070,000
Feb 17 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseA0.0030,000030,000
Feb 17 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseA7.9470,000555,80070,000
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,500037,500
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,500025,000
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.006,25006,250
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,50000
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS8.9621,353191,323839,178860.5 K to 839.2 K (-2.48 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,5000860,531848 K to 860.5 K (+1.47 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,5000848,031835.5 K to 848 K (+1.50 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.006,2500835,531829.3 K to 835.5 K (+0.75 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM0.0012,5000829,281816.8 K to 829.3 K (+1.53 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...Option ExerciseM0.005,000015,000
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...Option ExerciseM0.005,000010,000
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...Option ExerciseM0.002,34402,344
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...Option ExerciseM0.004,68800
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...SellS8.969,56485,69360,77270.3 K to 60.8 K (-13.60 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...BuyM0.005,000070,33665.3 K to 70.3 K (+7.65 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...BuyM0.005,000065,33660.3 K to 65.3 K (+8.29 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...BuyM0.002,344060,33658 K to 60.3 K (+4.04 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Kelly James PatrickSVP, CFO, Sec & Tre ...BuyM0.004,688057,99253.3 K to 58 K (+8.79 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.005,000015,000
Jan 06 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.005,000010,000
Jan 06 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...Option ExerciseM0.0012,500012,500
Jan 06 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...SellS8.9612,380110,92540,66553 K to 40.7 K (-23.34 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.005,000053,04548 K to 53 K (+10.41 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.005,000048,04543 K to 48 K (+11.62 %)
Jan 06 2016VNDAVanda Pharmaceutic ...Baroldi PaoloSVP & Chief Medical ...BuyM0.0012,500043,04530.5 K to 43 K (+40.92 %)
Dec 21 2015VNDAVanda Pharmaceutic ...BATE KENNETHDirectorOption ExerciseA9.3835,000328,30035,000
Dec 18 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.973,23929,0421,103,6171.1 M to 1.1 M (+0.29 %)
Dec 18 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.974,44139,8202,740,1222.7 M to 2.7 M (+0.16 %)
Dec 18 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.973,49031,2932,152,9522.1 M to 2.2 M (+0.16 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.6193,634806,0861,100,3781 M to 1.1 M (+9.30 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.61128,3741,105,1592,726,8952.6 M to 2.7 M (+4.94 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.61100,864868,3282,158,2482.1 M to 2.2 M (+4.90 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.5929,902256,8641,006,744976.8 K to 1 M (+3.06 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.5932,211276,6992,598,5212.6 M to 2.6 M (+1.26 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.5940,997352,1722,057,3842 M to 2.1 M (+2.03 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP9.0011,506103,554976,842965.3 K to 976.8 K (+1.19 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP9.0015,775141,9752,566,3102.6 M to 2.6 M (+0.62 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP9.0012,395111,5552,016,3872 M to 2 M (+0.62 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.21213,3581,751,883965,336752 K to 965.3 K (+28.37 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.21292,5152,401,8412,550,5352.3 M to 2.6 M (+12.95 %)
Dec 11 2015VNDAVanda Pharmaceutic ...Flynn James E10% OwnerBuyP8.21229,8331,887,1592,003,9921.8 M to 2 M (+12.95 %)
Sep 15 2015VNDAVanda Pharmaceutic ...Gulino Richard L.SVP & General Couns ...Option ExerciseA0.0050,000050,000
Sep 15 2015VNDAVanda Pharmaceutic ...Gulino Richard L.SVP & General Couns ...Option ExerciseA13.26150,0001,989,000150,000
Sep 11 2015VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM4.73147,626698,2710
Sep 11 2015VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM4.7342,747202,193147,626
Sep 11 2015VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS12.73102,1621,300,502816,781918.9 K to 816.8 K (-11.12 %)
Sep 11 2015VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM4.73147,626698,271918,943771.3 K to 918.9 K (+19.14 %)
Sep 11 2015VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS12.5129,577369,985771,317800.9 K to 771.3 K (-3.69 %)
Sep 11 2015VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM4.7342,747202,193800,894758.1 K to 800.9 K (+5.64 %)
Sep 09 2015VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP, General Manage ...Option ExerciseA0.0050,000050,000
Sep 09 2015VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP, General Manage ...Option ExerciseA12.68150,0001,902,000150,000
Jun 22 2015VNDAVanda Pharmaceutic ...COLA MICHAEL FDirectorOption ExerciseA13.0315,000195,45015,000
Jun 22 2015VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseA13.0315,000195,45015,000
Jun 22 2015VNDAVanda Pharmaceutic ...PIEN HOWARD HDirectorOption ExerciseA13.0315,000195,45015,000
Jun 22 2015VNDAVanda Pharmaceutic ...MILANO VINCENTDirectorOption ExerciseA13.0315,000195,45015,000
Jun 22 2015VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseA13.0315,000195,45015,000

Page:   < prev 1 2 3 4 5 6 ... 8 next >

Contact us | Follow us on Twitter